Mental Health

Jaguar Health Issues Shareholder Letter: Company to Explore Approval Pathway for Crofelemer in Breast and Lung Cancer Based on Phase 3 Results – Investor Webcast August 13th Will Review Q2 Earnings and Further Review OnTarget Trial’s Clinically Meaningful Results

Two Investigator-Initiated Responder Analysis Trials of Jaguar Health’s Crofelemer Show Significant Positive Results for Chronic Refractory Diarrhea in IBS-D: Data Accepted for Presentation at American College of Gastroenterology 2024 Annual Meeting

Two Investigator-Initiated Responder Analysis Trials of Jaguar Health’s Crofelemer Show Significant Positive Results for Chronic Refractory Diarrhea in IBS-D: Data Accepted for Presentation at American College of Gastroenterology 2024 Annual Meeting

Diagnostic Wearable Medical Devices Market size is set to grow by USD 8.76 billion from 2024-2028, Increasing prevalence of chronic diseases to boost the market growth, Technavio

Issuance of New European Patent Bolsters IP Protection for Jaguar Health in the Treatment of Congenital Diarrheal Disorders (CDDs)

New patent issued for core rare disease target indication for crofelemerJaguar has approximately 200 patents issued and pendingJaguar is supporting...

Healthcare IT Market size is set to grow by USD 199.8 billion from 2024-2028, Increasing focus on improving quality of services and efficiency to boost the market growth, Technavio

TELUS and University of Ottawa Heart Institute partner to boost emergency cardiac care efficiency with smartphone app

Streamlined communication between first responders, emergency doctors and cardiologists with Sayhut app reduces diagnosis time and improves treatment efficiency TORONTO, July...

error: Content is protected !!